A gummy composition including: 10 to 45 percent by weight of the composition of a protein, wherein a portion of the protein is hydrolyzed; Maltitol syrup; sugar; a structurant; and Water. A method of manufacture of a gummy composition including: Forming a mixture comprising 10 to 45 percent by weight of the composition of a protein, maltitol syrup, sugar, a structurant and water, wherein a portion of the protein is hydrolyzed; and cooking the mixture at a temperature of 85° C. or less.

Cannabinoid candy foodstuff compositions are described comprising a binding agent, and an emulsifier, wherein the composition includes a cannabinoid microemulsion and/or a cannabinoid nanoemulsion to enhance bioavailability of said cannabinoid when introduced into a human and/or an animal to have an active effect. The composition includes a biosynthetic cannabinoid derived from a genetically modified microorganism or a non-biosynthetic cannabinoid derived from cannabis plants, and may include an acid, an extrudate, a sugar coating, an insect lipid, a flavoring, a terpene, a medium chain triglyceride, glycerin, a microorganism, a sweetener, an oil, a drug such as psilocybin or MDMA, melatonin, a fiber-starch material, a density improving textural supplement, or a moisture improving textural supplement.

A semi-solid composition comprising a gelling component in a sufficient amount to provide a cohesive gelled product, a caffeinated component comprising caffeine, wherein the caffeinated component is bitter, and a complexing component, wherein the complexing component is configured to reduce the bitterness of the caffeinated component by complexing with the caffeinated component.

Gummies comprising soluble fiber in an amount of from about 40% to about 90% by weight on a dry solids basis; a gelling agent in an amount of from about 1% to about 25% by weight on a dry solids basis; a low-molecular weight saccharide or sugar alcohol in an amount of from about 1% to about 45% by weight on a dry solids basis; and water; wherein the gummy has a total dry solids content of from about 75% to about 90%, which exhibit an excellent set and excellent long-term storage, and methods of preparing same.

The present technology provides composition that includes pectin and a rare sugar, polydextrose, or a combination thereof; wherein the composition is a gummy and essentially free of gelatin. The composition has less than about 50 wt % sugar, a glycemic index of about 50 or less, about 10 calories or less, or a combination of two or more thereof. The gummy can be used to treat a patient such a patient with a nutritional deficiency or preventing a nutritional deficiency.

The present invention provides a method for producing a seamless centre filled gummy; wherein the filling comprises at least one active ingredient; the method comprising the steps of: 1) preparing a gelatinous shell composition by a first gelatine product in water to form a first gelatine solution; 2) preparing a filling composition, wherein the filling composition comprises at least one bulking agent and one or more active ingredients dissolved or suspended in said filling composition; 3) depositing the gelatinous shell composition and the filling composition within the same timeframe; 4) setting the deposited gelatinous shell composition; wherein the temperature T.sub.inner of the filling composition upon deposition is at most 45° C., and wherein the viscosity of the filling composition upon deposition ranges between 500 and 30000 mPa.Math.s. The invention further provides seamless centre filled gummy comprising an active ingredient, which may be produced by the inventive method.

The present invention defines a process for forming a chewable oral dosage form, such as a gum having a pleasant flavor and texture. In particular, the invention includes a process of forming an oral dosage form, comprising: a first step of hydrating a gelling agent of agar-agar and locust bean gum; a second step of mixing in components of the agar matrix; a third step of mixing in an active ingredient; a fourth step of cooking the mixture; a fifth step of flavoring; a sixth step of moulding and gelling; and a seventh step of demoulding, degreasing and drying. The oral dosage form according to the invention also comprises an agar-agar matrix combined with gums, such as locust bean gum, and/or sugar; glycerol; inulin; flavoring agents; citric acid; a coating; and water, to complete the composition, which includes active ingredients.

A method of improving flavor of a combination of a composition for increasing circulating ketone levels is disclosed. A composition containing (D)-β-hydroxybutyric acid (D-BHB), (D)-β-hydroxyvaleric acid (D-BHV), and (D)-1,3 butanediol (D-1,3BD) is disclosed. Exemplary compositions may be incorporated into food, supplement, and beverage products.

The present invention discloses a non-acidic-candy based composition for arresting or reversing dental caries by transforming the oral cavity from an acidic, bacteria-filled environment to an environment more conducive to remineralization by quickly neutralizing the acids recreated by ingestion of acidic compounds or by cariogenic bacteria while supplying necessary ions for tooth remineralization. This improves oral health, prevents pain and suffering, and serves as a conduit to deliver additional therapeutic agents. The composition comprises any combination of a calcium-based compound, a bicarbonate compound, a fluoride compound, an active ingredient, a therapeutic agent based on need, a non-cariogenic sweetener, a hydrating agent, at least one additive, and water. The composition is a candy that has a non-acidic-based composition which neutralizes acids while delivering necessary ions in a pH optimized environment to create the best possible conditions needed to arrest and/or reverse disease processes in the oral cavity and beyond.

The invention relates to modified release granular composition comprising melatonin and at least one non-swelling release controlling agent. The matrix granular composition as described herein may be specifically comprised of about 1 to 70% by weight of melatonin and about 10 to 70% by weight of non-swelling release controlling agent along with at least one excipient. The invention also relates to a process for preparation, wherein melatonin is uniformly embedded in at least one non-swelling release controlling agent using controlled heat conditions and the matrix granules may be optionally treated with non-swelling polymeric granulating agent to obtain modified release composition. The composition as described herein exhibits about 80% release of melatonin over 6-10 hours. The taste-masked granules can be formulated in suitable oral dosage forms which can be conveniently administered for improvement in quality of sleep to the subjects in need thereof.